2019 ´ëÇѳ»ºÐºñÇÐȸ Çп¬»ê ¹× Ãß°èÇмú´ëȸ : 2019-11-01±³À°ÀÏÀÚ : 2019-11-01
±³À°Àå¼Ò : ´ëÀüÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
2019 ´ëÇѳ»ºÐºñÇÐȸ Çп¬»ê ¹× Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ´ëÇѳ»ºÐºñÇÐȸ Ãß°èÇмú´ëȸ »ç¹«±¹
¿¬¶ôó : 070-7433-1755
À̸ÞÀÏ :
kes@cdmthebig.com ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ëÀü±¤¿ª½Ã±³À°½Ã°£ : 20 ½Ã°£ 48ºÐ
¼¼ºÎ¼ö°·á : 130,000¿ø
ºñ°í ¸¸ 65¼¼ ÀÌ»ó Æò»ý ȸ¿ø, Àü°øÀÇ, Çлý(Çкλý, ´ëÇпø»ý) [»çÀü,ÇöÀå ¹«·á]±ºÀÇ°ü, °øÁߺ¸°ÇÀÇ, °£È£»ç, ¿µ¾ç»ç [»çÀü 5¸¸¿ø / ÇöÀå 6¸¸¿ø]Àü¹®ÀÇ / ÀüÀÓÀÇ / ±âÃÊÀÇÇÐÀÚ (ȸ¿ø - Æò»ýȸ¿ø/Á¤È¸¿ø) [»çÀü 10¸¸¿ø / ÇöÀå11¸¸¿ø]Àü¹®ÀÇ / ÀüÀÓÀÇ / ±âÃÊÀÇÇÐÀÚ (ºñȸ¿ø) [»çÀü 12¸¸¿ø / ÇöÀå13¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-01 Room1 09:00~09:30 Management of thyroid nodules with Bethesda III, IV cytology ±èÅÂÇõ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-01 Room1 09:30~10:00 Strategy for follow up of DTC with low to intermediate risk of recurrence ±èº¸Çö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11-01 Room1 10:00~10:30 Thyroid dysfunction after cancer immunotherapy À±ÁöÈñ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-01 Room2 09:00~09:30 From clinical observations to target identification and therapeutic development Philip C. Tagari(Amgen)
±³À°½Ã°£ 11-01 Room2 09:30~10:00 Hit to Lead Process for Innovative Drug Discovery ÀÌ°æ(µ¿±¹´ë ¾àÇаú)
±³À°½Ã°£ 11-01 Room2 10:00~10:30 Accelerating drug discovery using a data-driven AI plaform ÀÌÁö¿µ(´ë±¸°æºÏ÷´ÜÀÇ·á»ê¾÷ÁøÈïÀç´Ü)
±³À°½Ã°£ 11-01 Room3 09:00~09:30 Role of Senescent T cells in Prediabetes ÀÌÇö½Â(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-01 Room3 09:30~10:00 Role of Metformin in inhibiting estrongen induced proliferation and regulating estrogen receptor expression in papillary thyroid carcinoma ÀÌÀμ®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-01 Room3 10:00~10:30 Effect of statin and ezetimibe on insulin resistance with prediabetes È«ÁØÈ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 11-01 Room4 09:00~09:30 °æµ¿¸ÆÃÊÀ½ÆÄÀDZâÃÊ(physics, Doppler, spectrum analysis) À±¼®±â(õ¾È¿£µµ³»°ú)
±³À°½Ã°£ 11-01 Room4 09:30~10:00 °æµ¿¸Æ ÇöóÅ©/ÇùÂøÀÇ Æò°¡ ±è¼ö°æ(Â÷ÀÇ°úÇдë)
ÈÞ½Ä 11-01 10:30~10:50 Coffee Break ()
±³À°½Ã°£ 11-01 Room1 10:50~11:20 Comparison of direct renin assay and plasma renin activity assay À̾ƶ÷(³ì½ÊÀÚÀÇ·áÀç´Ü Áø´Ü°Ë»çÀÇÇкΠƯ¼ö»ýÈÇÐÀ¯´Ö)
±³À°½Ã°£ 11-01 Room1 11:20~11:50 perioperative hemodynamic instability in pheochromocytoma ±è¼öÁø(¼¿ïÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 11-01 Room1 11:50~12:20 ºÎ½ÅÈ£¸£¸ó µî·Ï»ç¾÷: Çѱ¹ÀΠŸ¾× ³» ÄÚ¸£Æ¼¼Ö Âü°íÄ¡ Á¤¸³ ±èÈ¿Á¤(À»ÁöÀÇ´ë)
±³À°½Ã°£ 11-01 Room2 10:50~11:20 Prime opportunity - License to heal Á¤ÀçÈ£(¿¬¼¼ÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 11-01 Room2 11:20~11:50 When, how and what do I do for the strong patent? ·ùÁ¾¿ì(Á¦ÀÏƯÇã¹ýÀÎ)
±³À°½Ã°£ 11-01 Room2 11:50~12:20 How to secure budgets for investigator initiated trials? Á¶¿µ¹Î(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-01 Room3 10:50~11:10 Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer ±è¹ÎÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-01 Room3 11:10~11:30 Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells À¯¹ÌÇö(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 11-01 Room3 11:30~11:50 Functional Identification of Compound Heterozygous Mutations in the CYP17A1 Gene Resulting in Combined 17¥á-Hydroxylase/17,20-Lyase Deficiency ¸ðÀº¿µ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-01 Room3 11:50~12:10 Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults ÀÌ»ó¹è(¿¬¼¼ÀÇ´ë ³ë³â³»°ú)
±³À°½Ã°£ 11-01 Room3 12:10~12:20 Q & A ¹× ÅäÀÇ ()
±³À°½Ã°£ 11-01 Room4 10:50~11:12 Highly efficient base-editing in mice ±è°æ¹Ì(°í·ÁÀÇ´ë »ý¸®Çб³½Ç)
±³À°½Ã°£ 11-01 Room4 11:12~11:34 Parallel neural pathways for habit and controlled behavior in the primate brain ±è Çü(¼¿ï´ë »ý¸í°úÇкÎ)
±³À°½Ã°£ 11-01 Room4 11:34~11:56 New Candidate Genes for Metabolic Syndrome from Systemic Mouse Metabolic Phenotyping ¼ºÁ¦°æ(¼¿ï´ë ¼öÀÇÇаú/KMPC)
±³À°½Ã°£ 11-01 Room4 11:56~12:18 Analysis of skeletal tissue diseases using genetically modified mouse models ÃÖÁ¦¿ë(°æºÏÀÇ´ë »ýÈÇС¤¼¼Æ÷»ý¹°Çб³½Ç)
½Ä»ç 11-01 Room1 12:20~13:10 Luncheon Lecture I ()
½Ä»ç 11-01 Room2 12:20~13:10 Luncheon Lecture II ()
±³À°½Ã°£ 11-01 Room1 13:10~13:50 Digital healthcare: Can it open the new era of patients management? À±°ÇÈ£(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 11-01 14:15~14:30 Coffee Break ()
±³À°½Ã°£ 11-01 Room5 14:00~14:30 Hands-on À±¼®±â(õ¾È¿£µµ³»°ú)
±³À°½Ã°£ 11-01 Room5 14:30~15:00 Hands-on ±èÁ¾È(ºÎõ¼¼Á¾º´¿ø)
±³À°½Ã°£ 11-01 Room1 14:30~15:00 Remodeling of calcified endplate by teriparatide (rhPTH 1-34), a potential treatment of osteoporosis with discogenic low back pain Zou Xuenong(Sun Yat-sen University)
±³À°½Ã°£ 11-01 Room1 15:00~15:30 Senescent phenotypes of chondrocytes govern the pathogenesis of osteoarthritis. ±èÁøÈ«(¼¿ï´ë »ý¸í°úÇкÎ)
±³À°½Ã°£ 11-01 Room1 15:30~16:00 Overcoming osteoporosis and beyond: Locomotive syndrome or dysmobility syndrome (tentative) À̽ÃÈÆ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-01 Room2 14:30~15:00 ½Å¾àÈĺ¸ ¹°ÁúÀ» ¾î¶² °üÁ¡À¸·Î Æò°¡Çؼ ȸ»ç¿¡¼ ±â¼úÀÌÀüÀ» ¹Þ´Â °áÁ¤À» ÇÏ´ÂÁö? (±â¼úÀ» »ç´Â ÀÔÀå)(¹ÌÁ¤) ÀÌÁ¤±Ô(ºê¸´Áö¹ÙÀÌ¿À)
±³À°½Ã°£ 11-01 Room2 15:00~15:30 Strategies and Solutions to Partnering with Pharma Chris Vlahos(lpsen)
±³À°½Ã°£ 11-01 Room1 16:00~16:30 Metabolic characteristics of patients with acromegaly Zhaoyun Zhang(Huashan Hospital Fudan University)
±³À°½Ã°£ 11-01 Room1 16:30~17:00 Progress in the genetic study of pituitary adenomas Qilin Zhang(Neurosurgery, Huashan Hospital Fudan University)
±³À°½Ã°£ 11-01 Room1 17:00~17:30 Hypophysectomized Rats and Pituitary Transplantation ¾ç½ÂÈ£(°¡Å縯ÀÇ´ë ½Å°æ¿Ü°ú)
±³À°½Ã°£ 11-01 Room2 15:30~16:00 ÀÇ·á µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ µö·¯´× ±â¼ú °³¹ßÀÇ °úÁ¤ ±è±âȯ(·ç´Ö)
±³À°½Ã°£ 11-01 Room2 16:00~16:30 ÀÓ»óÀÇ°¡ ½ÃÀÛÇÏ´Â Medical informatics ¿¬±¸ À±´ö¿ë(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11-01 Room2 16:30~17:00 ºí·ÏüÀΰú ÇコÄɾî, ±×¸®°í °³Àΰǰ±â·Ï(PHR) ÀÌÀº¼Ö(¸Þµðºí·Ï)
±³À°½Ã°£ 11-01 Room2 17:00~17:30 A lagre population based genome study for Type 2 diabetes ±èºÀÁ¶(Áúº´°ü¸®º»ºÎ À¯Àüü¿¬±¸°ú)
±³À°½Ã°£ 11-01 Room3 16:00~16:25 °Ç°º¸ÇèÁ¤Ã¥ÀÇ º¯È ¹æÇâ ÀÌÁß±Ô(º¸°Çº¹ÁöºÎ)
±³À°½Ã°£ 11-01 Room3 16:25~16:50 ¿ø°¡ºÐ¼® Çʿ伺 ¹× È°¿ë¹æ¾È" (±Þ¿©Àü·«½Ç ¿ø°¡ºÐ¼®ºÎÀå) ±èÁö¿µ(±¹¹Î°Ç°º¸Çè°ø´Ü)
±³À°½Ã°£ 11-01 Room3 16:50~17:15 3Â÷ »ó´ë°¡Ä¡ °³Æí ÇöȲ ¹× °úÁ¦ ¹®°æ¾Æ(°Ç°º¸Çè½É»çÆò°¡¿ø)
±³À°½Ã°£ 11-01 Room3 17:15~17:40 Panel Discussion ¹Ú°æÇý(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø)